Skip to content

CMC and manufacturing

Biologics CDMOs.

Contract development and manufacturing organizations documenting biologics process development and GMP manufacturing, segmented by modality, expression platform, drug substance or drug product, and stage. 20 published profiles.

New to selecting a provider? Choosing a CDMO: a practical guide

20 providers

Ordered alphabetically. No paid placement.

  • 3PBIOVIAN

    3pbiovian.com

    3PBIOVIAN, formed from 3P Biopharmaceuticals and Biovian, describes process, cell line and analytical development and GMP manufacturing of microbial and mammalian proteins, including monoclonal antibodies, plus AAV and adenovirus vectors and plasmid DNA, for drug substance and in-house fill and finish, from preclinical to commercial supply. It lists manufacturing sites in Noáin (Pamplona), Spain and Turku, Finland.

    Services
    Analytical development and QC testing · Cell line development · Clinical packaging and labeling · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Microbial fermentation · Single-use bioreactors · Cell therapies
    Locations
    Europe · North America
    View profile

    Sources reviewed November 4, 2026

  • Abzena

    abzena.com

    Abzena describes cell line development (CHO), process development and cGMP drug substance manufacturing of monoclonal antibodies and recombinant proteins at San Diego, CA, using single-use bioreactors, for clinical and commercial supply. Its Bristol, PA site documents bioconjugation, ADC and highly potent manufacturing; a Cambridge, UK site covers discovery. Corporate headquarters are in Raleigh, NC.

    Services
    Analytical development and QC testing · Bioconjugation (ADC) · Cell line development · Formulation development · GMP drug substance manufacturing · Highly potent APIs · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Antibody-drug conjugates · Monoclonal antibodies
    Locations
    Europe · North America
    View profile

    Sources reviewed November 4, 2026

  • AGC Biologics

    agcbio.com · Part of AGC Inc.

    AGC Biologics describes process, cell line, analytical and formulation development and cGMP drug substance manufacturing of mammalian and microbial proteins, including monoclonal antibodies, plus mRNA, viral vectors and cell therapies, from Phase I to commercial supply. It lists headquarters in Bothell, WA and sites in Copenhagen, Heidelberg, Milan, Chiba and Yokohama, and states it is part of AGC Inc.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Lyophilization · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Microbial fermentation · Single-use bioreactors · Cell therapies
    Locations
    Asia-Pacific · Europe · North America
    View profile

    Sources reviewed November 3, 2026

  • Aragen

    aragen.com

    Aragen, a CRDMO that also serves small-molecule programmes, describes biologics cell line development (CHO) in Morgan Hill, California and upstream, downstream and analytical development and cGMP clinical drug substance manufacturing of monoclonal antibodies in single-use bioreactors at Jigani, Bengaluru, India. Biologics drug product manufacturing is not documented. Its global headquarters is in Hyderabad, India.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug substance manufacturing · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Monoclonal antibodies
    Locations
    Asia-Pacific · North America
    View profile

    Sources reviewed November 4, 2026

  • Avid Bioservices

    avidbio.com

    Avid Bioservices describes cell line, process, analytical and liquid formulation development and CGMP drug substance manufacturing of monoclonal antibodies and recombinant proteins in CHO cells, from Phase I to commercial supply, plus conjugation of ADCs with non-potent payloads. It lists headquarters and manufacturing in Tustin, CA and an early-phase center in Costa Mesa, CA.

    Services
    Analytical development and QC testing · Bioconjugation (ADC) · Cell line development · Formulation development · GMP drug substance manufacturing · Lyophilization · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Antibody-drug conjugates · Monoclonal antibodies
    Locations
    North America
    View profile

    Sources reviewed November 3, 2026

  • Bionova Scientific

    bionovascientific.com · Part of Asahi Kasei

    Bionova Scientific describes mammalian cell line development, process, analytical and formulation development, and GMP manufacturing of monoclonal antibodies and recombinant proteins from DNA to bulk drug substance in single-use bioreactors, at a facility described as commercial-ready and producing clinical supply. It lists headquarters in Fremont, CA, and is described as a subsidiary of Asahi Kasei.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug substance manufacturing · Process development · Stability studies
    Specialties
    Mammalian cell culture · Single-use bioreactors · Monoclonal antibodies · mRNA and nucleic acids
    Locations
    North America
    View profile

    Sources reviewed November 4, 2026

  • Celonic

    celonic.com

    Celonic documents cell line development (CHO), process and analytical development and GMP drug substance manufacturing for monoclonal antibodies, bispecifics and fusion proteins, from clinical supply to commercial manufacturing. It lists its headquarters and development center in Basel, Switzerland, and single-use GMP manufacturing in Heidelberg, Germany.

    Services
    Analytical development and QC testing · Cell line development · GMP drug substance manufacturing · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Monoclonal antibodies · Recombinant proteins
    Locations
    Europe
    View profile

    Sources reviewed November 3, 2026

  • Curia

    curiaglobal.com

    Curia describes mammalian cell line and process development and GMP drug substance manufacturing of antibodies, proteins, vaccines and mRNA at Hopkinton, MA, and formulation development and sterile fill-finish (liquid and lyophilized) for biologics and small molecules at Camarillo, CA, Glasgow and, for commercial supply, Albuquerque, NM. It also runs small-molecule services outside this profile. It was formerly AMRI.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Lyophilization · Process development · Stability studies · Technology transfer
    Specialties
    Single-use bioreactors · Monoclonal antibodies · mRNA and nucleic acids · Recombinant proteins
    Locations
    Europe · North America
    View profile

    Sources reviewed November 4, 2026

  • Enzene

    enzene.com

    Enzene describes cell line, process and formulation development and GMP drug substance manufacturing of monoclonal antibodies and other recombinant proteins from mammalian (CHO) and microbial (E. coli) systems, in fed-batch or continuous mode, with in-house fill and finish of vials, prefilled syringes and cartridges. It lists manufacturing in Chakan (Pune), India, a corporate office in Pune and a New Jersey site.

    Services
    Cell line development · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Lyophilization · Process development · Stability studies
    Specialties
    Mammalian cell culture · Microbial fermentation · Single-use bioreactors · Monoclonal antibodies
    Locations
    Asia-Pacific · North America
    View profile

    Sources reviewed November 3, 2026

  • FUJIFILM Biotechnologies

    fujifilmbiotechnologies.fujifilm.com

    FUJIFILM Biotechnologies documents cell line, process, analytical and formulation development and cGMP drug substance and aseptic drug product manufacturing using mammalian (CHO) and microbial systems, plus viral vector and cell therapy manufacturing, from Phase I to commercial supply. It lists manufacturing sites in North Carolina, Texas and California (US), Hillerød (Denmark) and Teesside (UK).

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Highly potent APIs · Process development · Stability studies
    Specialties
    Mammalian cell culture · Microbial fermentation · Single-use bioreactors · Cell therapies
    Locations
    Asia-Pacific · Europe · North America
    View profile

    Sources reviewed November 4, 2026

  • Just – Evotec Biologics

    evotec.com · Part of Evotec SE

    Just – Evotec Biologics describes cell line (J.CHO), process, analytical and formulation development and continuous cGMP drug substance manufacturing of monoclonal, bispecific and Fc-fusion antibodies in single-use bioreactors, from first-in-human to commercial supply; drug product is not documented. It lists sites in Seattle and Redmond, Washington, and states it is a subsidiary of Evotec SE.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug substance manufacturing · Process development · Stability studies
    Specialties
    Mammalian cell culture · Single-use bioreactors · Monoclonal antibodies · Recombinant proteins
    Locations
    North America
    View profile

    Sources reviewed November 3, 2026

  • KBI Biopharma

    kbibiopharma.com · Part of JSR Life Sciences

    KBI Biopharma documents cell line development, process, analytical and formulation development, and cGMP drug substance manufacturing for biologics from first-in-human to commercial supply. It lists mammalian (CHO, single-use) manufacturing in Durham, NC, microbial (E. coli) manufacturing in Boulder, CO, and laboratories in Louisville, CO and Geneva, Switzerland. It names JSR Life Sciences as its parent company.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug substance manufacturing · Lyophilization · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Microbial fermentation · Single-use bioreactors · Monoclonal antibodies
    Locations
    Europe · North America
    View profile

    Sources reviewed November 3, 2026

  • Kemwell Biopharma

    kemwellbiopharma.com

    Kemwell Biopharma describes cell line, process, analytical and formulation development and cGMP drug substance and drug product manufacturing (liquid and lyophilized vials, prefilled syringes) for mammalian cell culture proteins, including monoclonal antibodies, fusion proteins and bispecifics, with Phase III and commercial supply. It lists its headquarters and facilities in Bengaluru, India.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Lyophilization · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Monoclonal antibodies · Recombinant proteins
    Locations
    Asia-Pacific
    View profile

    Sources reviewed November 3, 2026

  • Mabion

    mabion.eu

    Mabion describes cell line, process and analytical method development and clinical and commercial drug substance manufacturing of monoclonal antibodies and other therapeutic proteins using mammalian (CHO) and insect cell lines in single-use bioreactors. Drug product manufacturing is not documented on current pages. It lists its headquarters in Konstantynów Łódzki, Poland.

    Services
    Analytical development and QC testing · Cell line development · GMP drug substance manufacturing · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Monoclonal antibodies · Recombinant proteins
    Locations
    Europe
    View profile

    Sources reviewed November 3, 2026

  • Northway Biotech

    northwaybiotech.com

    Northway Biotech describes cell line and strain, process, analytical and formulation development and cGMP drug substance and drug product (fill and finish) manufacturing of antibodies and recombinant proteins from mammalian and microbial systems, plus plasmid DNA, viral vectors and cell therapies, for clinical and commercial supply. It lists biologics sites in Vilnius, Lithuania and Waltham, Massachusetts.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Lyophilization · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Microbial fermentation · Single-use bioreactors · Cell therapies
    Locations
    Europe · North America
    View profile

    Sources reviewed November 4, 2026

  • ProBioGen

    probiogen.de

    ProBioGen documents CHO and HEK293 cell line development, process, analytical and formulation development, and GMP drug substance manufacturing of antibodies and recombinant proteins in single-use bioreactors up to 1000L for preclinical and clinical supply. It also describes process development and GMP manufacturing of viral vectors and vaccines, including in-house vial filling. It is based in Berlin, Germany.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Gene therapies · Monoclonal antibodies
    Locations
    Europe
    View profile

    Sources reviewed November 4, 2026

  • Rentschler Biopharma

    rentschler-biopharma.com

    Rentschler Biopharma describes cell line development, process, analytical and formulation development, and cGMP drug substance manufacturing of recombinant proteins and monoclonal antibodies for clinical and commercial supply. It lists headquarters and manufacturing in Laupheim, Germany, and a manufacturing site in Milford, MA, USA with single-use bioreactors.

    Services
    Analytical development and QC testing · Cell line development · Formulation development · GMP drug substance manufacturing · Process development · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Monoclonal antibodies · Recombinant proteins
    Locations
    Europe · North America
    View profile

    Sources reviewed November 4, 2026

  • Resilience

    resilience.com

    Resilience (National Resilience) describes cell line, process, analytical and formulation development, mammalian drug substance manufacturing of monoclonal antibodies and recombinant proteins in single-use bioreactors, and sterile fill/finish, from preclinical to commercial supply. It lists headquarters in Blue Ash, Ohio, drug substance and vial filling near Toronto, and drug product at West Chester, Ohio.

    Services
    Analytical development and QC testing · Bioconjugation (ADC) · Cell line development · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Monoclonal antibodies · Peptides
    Locations
    North America
    View profile

    Sources reviewed November 3, 2026

  • Samsung Biologics

    samsungbiologics.com

    Samsung Biologics documents cell line development, process, formulation and analytical development, and cGMP drug substance and aseptic fill-finish drug product manufacturing for monoclonal antibodies, recombinant proteins, mRNA and ADCs, from IND-stage to commercial supply. It lists manufacturing campuses in Songdo (Incheon, South Korea) and Rockville, Maryland, and offices in the US, Tokyo and Amsterdam.

    Services
    Analytical development and QC testing · Bioconjugation (ADC) · Cell line development · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Highly potent APIs · Lyophilization · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Single-use bioreactors · Antibody-drug conjugates · Monoclonal antibodies
    Locations
    Asia-Pacific · Europe · North America
    View profile

    Sources reviewed November 3, 2026

  • WuXi Biologics

    wuxibiologics.com

    WuXi Biologics documents cell line, process, analytical and drug product development and cGMP drug substance and aseptic drug product manufacturing for antibodies and recombinant proteins using mammalian and microbial systems, from preclinical to commercial supply. It lists manufacturing sites in China (Wuxi, Shanghai, Suzhou, Hangzhou, Hebei), New Jersey, Massachusetts, Ireland, Germany and Singapore.

    Services
    Analytical development and QC testing · Cell line development · Clinical packaging and labeling · Formulation development · GMP drug product manufacturing · GMP drug substance manufacturing · Lyophilization · Process development · Stability studies · Technology transfer
    Specialties
    Mammalian cell culture · Microbial fermentation · Single-use bioreactors · Antibody-drug conjugates
    Locations
    Asia-Pacific · Europe · North America
    View profile

    Sources reviewed November 4, 2026

Select two to 4 providers to compare side by side.

ArgusBio sourcing

Need help evaluating these providers.

Public capabilities are a starting point. ArgusBio can help you define the scope, confirm what matters (available capacity, slot timing and scale for your next campaign, capacity, timelines) and compare proposals consistently.

Discuss a sourcing need

We work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.